INTRODUCTION
The importance of inflammation in the progression of cancer and cardiovascular disease has recently become apparent. 1 The ability to monitor how inflammation progresses in vivo may provide a more complete understanding of the development and treatment of these diseases. In order to accomplish this, it is necessary to employ methodologies that allow the different stages of inflammation to be mapped. For practices such as magnetic resonance imaging (MRI), lanthanide(III) ion-based CAs have been shown to provide optimal effects on the relaxation rates of water protons in order to differentiate between tissues and aid in more meaningful diagnostics.
However, lanthanide ions, such as gadolinium(III), are toxic in vivo and must therefore be chemically altered in order to be clinically useful. 2 The advantage chelates offer for the modification of xenobiotic metal ions in MRI are twofold: a reduction in toxicity and the possibility of an increase in relaxivity to provide superior contrast. A main aim in the development of contrast agents (CAs) is to design structures specifically to differentiate various inflammation types, which are characterized by the localization of macrophages that can conveniently be targeted with nano-scale particulate agents that are then endocytosed. 3 Thus, the design of chelates suitable for the coordination of lanthanide ions has become a prevalent field of study, seated at a junction between inorganic coordination chemistry and organic synthesis in an overarching aim to diagnose and treat cancer.
Clinical contrast agents (CAs) for computed tomography (CT) imaging include high atomic number (Z) ions as X-ray attenuating agents; clinically they are largely comprised of small iodinated molecules such as iopamidol, iohexol and iodixanol. 4 Although iodine is relatively electron dense and effective in X-ray attenuation, current CAs have limited utility in their capacity to target tissues. 5 Bismuth nanoparticles (Bi-NPs) have become an increasingly attractive candidate for CT contrast agents due to low toxicity, high electron density, stability and surface modification capability. 6, 7 Synthesis of the nanoparticles published typically range from 30 to 80 nm in size, formed largely by the pH dependent reduction of bismuth(III) cations. The nano-encapsulation process first involves synthesizing a polyanionic metal complex. Then, as shown in Figure 1 , an aggregate of the chelate with a cationic polymer, in this case polyallylamine hydrochloride (PAH), is formed and encapsulated by a silica nanoparticle shell. The average size of gadolinium-based NACs was found to increase proportionally with the ratio of the concentration of charges on the anionic complex and cationic polymer; a term expressed as the R value (Eqn 1).
As the value of R was increase from 0.3 to 1.25 for Gd-DOTP 5-and Gd-TTHA 3-based NACs prepared in a solvent system of 3:2 v/v acetonitrile/water the capsule size increased correspondingly. 9 Bismuth complexes of the same ligands (DOTP and TTHA) were anticipated to facilitate capsule formation in much the same way as the Gd 3+ chelates and to exhibit a similar trend in the relationship between the R value to the size of particle in a similar solvent system. synthetic protocols have been previously published. 10, 11 However, the BiTTHA 3-complex when synthesized was found to be insoluble in water and therefore could not be utilized in this study. 
Bi-DOTP Synthesis
The synthesis of Bi 3+ DOTP complexes was carried out by the addition of Bi2O3 at pH 0 in nitric acid portion wise to a solution of H8DOTP at pH = 4 -5 with heating. The progress of the chelation reaction was then monitored by potassium iodide tests to indicate whether any free bismuth was left in solution. If any free ion was detected, more ligand was added. Once all bismuth was complexed, the solution was freeze-dried to remove solvent. The resulting powder was weighed and dissolved in a small amount of water to create a stock solution from which all experiments were conducted.
NAC Preparation
A 8.9 μM stock solution of PAH was prepared by dissolving PAH (0.0498 g, 0.89 μmol) in a mixture correspondent to the solvent system being analyzed (10 mL). The pH of the chelate stock solution was adjusted to 9 by NaOH. A stock 2% suspension of SNPs was prepared by adding 1 mL of a commercially available 20.2 wt% suspension of SNPs in water to 9 mL of MeCN. Upon addition of the chelate stock solution the reaction became turbid indicating the formation of an aggregate. Aggregates were aged for 10 minutes before addition of the 2% SNP stock solution (100 μL). The reaction was vortexed for a further 10 seconds at medium speed and then allowed to age without agitation for 30 minutes. Excess SNPs were removed by filter centrifugation using 10 kDa MWCO filter centrifuge tube at 6,000 rpm. The NACs retained in the filter centrifuged tube were washed with water and filtered by centrifugation for 30 minutes at 14,000 rpm a total of six times. The NACs were then taken up into water (1 mL) and recovered into a sample vial.
Microscopy
Scanning electron microscopy (SEM) was performed on a FEI (Hillsboro, OR, USA) Sirion FEG electron microscope equipped with an energy dispersive X-ray (EDX) detector. A droplet of NACs suspension was placed on the aluminium stub and dried in air. The sample was then sputter coated with gold for 55 seconds. Secondary electron images were taken at 5 kV with a working distance between 5-10 mm.
Dynamic Light Scattering
Dynamic light scattering was performed on a Horiba (Irvine, CA, USA) LB-550 dynamic light scattering instrument. For these measurements freshly syringe filtered samples were dispersed in water and measured at four dilutions to ensure size distributions were independent of concentration effects. Samples were regularly agitated to guard against settling of larger particles. To determine whether Bi-DOTP interacted similarly with the PAH polymer as Gd-DOTP, the R value of Bi-DOTP NACs was varied to conclude whether the linear relationship with size distribution exists for the novel NACs in comparison to Gd-NACs, displayed in Fig. 4 .
Initial preparations of NACs containing
. When the temperature was decreased to 0˚C, there was not a decrease in the size distribution of the particles as expected, with the exception of aging times 3 and 5 minutes in 1:1 v/v MeCN/water solvent system. Generally, the average size of capsule tended to increase with a decrease in temperature in the EtOH/water solvent system and the magnitude of the sizes remained too large for a viable comparison with Bi-NPs.
In conclusion, the formation of NACs containing Bi-DOTP complexes was confirmed. However, the size distribution of the particles was highly inconsistent. As a result the contrast efficacy was not established. Moving forward, further research should focus on additional chelates to determine whether the size distributions are consistent in bismuth-based NACs in an effort to interpret the disparity in the ability of bismuth complexes to interact with the polymers in a similar manner as Gd-based counterparts. Furthermore, varied cationic polymers could also be studied to determine whether PAH is unique in its interactions with Bi-DOTP. Flow cytometry studies could potentially be utilized to compare contrast on a per-NAC basis with Bi-NPs of similar size. Further studies in this work will focus on a method to separate the particles into more narrow size distributions. Once this is accomplished and a method of comparing Bi-NACs with Bi-NPs on a per-particle basis is established, series of phantoms containing Bi-NACs and Bi-NPs at different concentrations should be imaged to assess the effects on particle size and Bi 3+ density on the ability to generate contrast in CT images. These experiments would allow for the identification of the agents suitable for CT contrast agents and once complete could lead to the modification of the particle synthesis to ensure adequate stability (and possible functionalization) necessary.
CONCLUSIONS
Additional work could begin to examine how different genotypes of macrophage respond to each different nano-particle. In particular, the investigation into the extent to which one nano-particle may be favored for endocytosis by one genotype over another.
